| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-587 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-40 |
| filingDate |
1984-10-30^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-05-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82800d430b65c6f20d215ace10eafe3b |
| publicationDate |
1987-05-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4665167-A |
| titleOfInvention |
Manufacture of antibiotics |
| abstract |
The invention provides crystalline (Z)-2-(2-t-butoxycarbonyl-prop-2-oxyimino)-2-(2-triphenylmethylaminoth iazol-4-yl)acetic acid in association with dioxan and its crystalline ethyl ester in association with methanol. The compounds are of value as intermediates in the preparation of beta -lactam antibiotics such as ceftazidime or azthreonam. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6214997-B1 |
| priorityDate |
1981-11-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |